C186H214N32O31 — CID 159456291
methyl N-[(2S)-1-[(2S)-2-[7-[2-[(1R,3S,4S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[2.2.1]heptan-3-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(1S)-2-[(8S)-8-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzo[e]benzimidazol-7-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-1,4-dioxa-7-azaspiro[4.4]nonan-7-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate;methyl N-[(2S)-1-[(2S)-2-[7-[2-[(1R,3S,4S)-2-[(2S,3R)-3-methoxy-2-(methoxycarbonylamino)butanoyl]-2-azabicyclo[2.2.1]heptan-3-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(2S)-1-[(2S)-2-[7-[2-[(8S)-7-[(2S,3R)-3-methoxy-2-(methoxycarbonylamino)butanoyl]-1,4-dioxa-7-azaspiro[4.4]nonan-8-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate (PubChem CID 159456291) has the molecular formula C186H214N32O31 and a molecular weight of 3393.95 g/mol. Its IUPAC name is methyl N-[(2S)-1-[(2S)-2-[7-[2-[(1R,3S,4S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[2.2.1]heptan-3-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(1S)-2-[(8S)-8-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzo[e]benzimidazol-7-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-1,4-dioxa-7-azaspiro[4.4]nonan-7-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate;methyl N-[(2S)-1-[(2S)-2-[7-[2-[(1R,3S,4S)-2-[(2S,3R)-3-methoxy-2-(methoxycarbonylamino)butanoyl]-2-azabicyclo[2.2.1]heptan-3-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(2S)-1-[(2S)-2-[7-[2-[(8S)-7-[(2S,3R)-3-methoxy-2-(methoxycarbonylamino)butanoyl]-1,4-dioxa-7-azaspiro[4.4]nonan-8-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate.
| Compound Name | methyl N-[(2S)-1-[(2S)-2-[7-[2-[(1R,3S,4S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[2.2.1]heptan-3-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(1S)-2-[(8S)-8-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzo[e]benzimidazol-7-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-1,4-dioxa-7-azaspiro[4.4]nonan-7-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate;methyl N-[(2S)-1-[(2S)-2-[7-[2-[(1R,3S,4S)-2-[(2S,3R)-3-methoxy-2-(methoxycarbonylamino)butanoyl]-2-azabicyclo[2.2.1]heptan-3-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(2S)-1-[(2S)-2-[7-[2-[(8S)-7-[(2S,3R)-3-methoxy-2-(methoxycarbonylamino)butanoyl]-1,4-dioxa-7-azaspiro[4.4]nonan-8-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate |
|---|---|
| PubChem CID | 159456291 |
| Molecular Formula | C186H214N32O31 |
| Molecular Weight | 3393.95 g/mol |
| Exact Mass | 3391.62 |
| IUPAC Name | methyl N-[(2S)-1-[(2S)-2-[7-[2-[(1R,3S,4S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[2.2.1]heptan-3-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(1S)-2-[(8S)-8-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzo[e]benzimidazol-7-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-1,4-dioxa-7-azaspiro[4.4]nonan-7-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate;methyl N-[(2S)-1-[(2S)-2-[7-[2-[(1R,3S,4S)-2-[(2S,3R)-3-methoxy-2-(methoxycarbonylamino)butanoyl]-2-azabicyclo[2.2.1]heptan-3-yl]-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(2S)-1-[(2S)-2-[7-[2-[(8S)-7-[(2S,3R)-3-methoxy-2-(methoxycarbonylamino)butanoyl]-1,4-dioxa-7-azaspiro[4.4]nonan-8-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate |
| SMILES | COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2c(ccc3cc(-c4ccc5c(c4)CCc4[nH]c([C@@H]6CC7(CN6C(=O)[C@@H](NC(=O)OC)C6CCOCC6)OCCO7)nc4-5)ccc32)[nH]1)C(C)C.COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2c(ccc3cc(-c4ccc5c(c4)CCc4[nH]c([C@@H]6CC7(CN6C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC)OCCO7)nc4-5)ccc32)[nH]1)C(C)C.COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2c(ccc3cc(-c4ccc5c(ccc6[nH]c([C@@H]7[C@H]8CC[C@H](C8)N7C(=O)[C@@H](NC(=O)OC)C(C)C)nc65)c4)ccc32)[nH]1)C(C)C.COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2c(ccc3cc(-c4ccc5c(ccc6[nH]c([C@@H]7[C@H]8CC[C@H](C8)N7C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC)nc65)c4)ccc32)[nH]1)C(C)C |
| InChI | InChI=1S/C48H56N8O9.C46H54N8O9.C46H52N8O7.C46H52N8O6/c1-26(2)38(53-46(59)61-3)44(57)55-17-5-6-36(55)42-49-34-13-9-30-22-28(7-11-32(30)40(34)51-42)29-8-12-33-31(23-29)10-14-35-41(33)52-43(50-35)37-24-48(64-20-21-65-48)25-56(37)45(58)39(54-47(60)62-4)27-15-18-63-19-16-27;1-24(2)36(51-44(57)60-5)42(55)53-17-7-8-34(53)40-47-32-15-11-28-20-26(9-13-30(28)38(32)49-40)27-10-14-31-29(21-27)12-16-33-39(31)50-41(48-33)35-22-46(62-18-19-63-46)23-54(35)43(56)37(25(3)59-4)52-45(58)61-6;1-23(2)36(51-45(57)60-5)43(55)53-19-7-8-35(53)41-47-33-17-12-27-20-25(10-15-31(27)38(33)49-41)26-11-16-32-28(21-26)13-18-34-39(32)50-42(48-34)40-29-9-14-30(22-29)54(40)44(56)37(24(3)59-4)52-46(58)61-6;1-23(2)36(51-45(57)59-5)43(55)53-19-7-8-35(53)41-47-33-17-12-27-20-25(10-15-31(27)38(33)49-41)26-11-16-32-28(21-26)13-18-34-39(32)50-42(48-34)40-29-9-14-30(22-29)54(40)44(56)37(24(3)4)52-46(58)60-6/h7-9,11-13,22-23,26-27,36-39H,5-6,10,14-21,24-25H2,1-4H3,(H,49,51)(H,50,52)(H,53,59)(H,54,60);9-11,13-15,20-21,24-25,34-37H,7-8,12,16-19,22-23H2,1-6H3,(H,47,49)(H,48,50)(H,51,57)(H,52,58);10-13,15-18,20-21,23-24,29-30,35-37,40H,7-9,14,19,22H2,1-6H3,(H,47,49)(H,48,50)(H,51,57)(H,52,58);10-13,15-18,20-21,23-24,29-30,35-37,40H,7-9,14,19,22H2,1-6H3,(H,47,49)(H,48,50)(H,51,57)(H,52,58)/t36-,37-,38-,39-;25-,34+,35+,36+,37+;24-,29+,30-,35+,36+,37+,40+;29-,30+,35-,36-,37-,40-/m0110/s1 |
| InChIKey | LTZZYFLIHMJCFP-XOTYGGOISA-N |
| XLogP | 26.93 |
| TPSA | 763.17 Ų |
| H-Bond Donors | 16 |
| H-Bond Acceptors | 39 |
| Rotatable Bonds | 38 |
| Heavy Atoms | 249 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3393.95 |
| LogP ≤ 5 | 26.93 |
| H-Bond Donors ≤ 5 | 16 |
| H-Bond Acceptors ≤ 10 | 39 |